Brought to you by:
Survey suggests greater exposure to mini-incision carotid endarterectomy during training may dispel perceived limitations to approach
While a recent survey found that a majority of those who responded had performed mini-incision carotid endarterectomy (CEA) at least once in their practice careers, most answered that they did not perform the surgery routinely. In the world of general…
Equivalent outcomes seen among female, male patients in real-world analysis of paclitaxel-eluting stent use
The use of a paclitaxel-eluting stent to treat femoropopliteal occlusive disease led to equivalent outcomes in male and female patients in “a diverse and complex real-world cohort,” a new study found, set against previous question marks over the effectiveness of…
New study validates BEST-CLI trial results, ‘suggesting generalizability’
A new propensity-matched analysis of more than 1,100 lower extremity revascularization procedures carried out in patients with chronic limb-threatening ischemia (CLTI)—which aimed to help solve the puzzle of why the BEST-CLI trial did not lead to a pick-up in the…
‘The leader must own everything in his or her world, own every mistake and credit the team for successes’
“We can almost be considered a specialty of colonizers, acquiring borrowed techniques. Why, then, do we see ourselves as the keepers of vascular care? Why do we think that we are the ones that can deliver the best vascular care?…
The question of Vascular Surgery Board independence: Federated or free-standing?
A survey recently went out to Society for Vascular Surgery (SVS) members asking them to contribute their voice to an opinion poll over whether the Vascular Surgery Board (VSB) should remain a constituent board of the American Board of Surgery…
VenoValve: Analysis finds similar improvement among both primary and thrombotic deep venous reflux patients
A new subanalysis of the SAVVE (Surgical antireflux venous valve endoprosthesis) trial found that there was no difference in the level of improvement in clinical outcomes and quality-of-life measures between patients who have either primary or thrombotic deep venous reflux.…
SCVS 2025: Rowe becomes SCVS president
Vincent Rowe, MD, from the University of California, Los Angeles (UCLA), became the 2025–26 Society for Clinical Vascular Surgery (SCVS) president during the Society’s 52nd Annual Symposium in Austin, Texas (March 29–April 2). Falling in line behind him are Peter…
SCVS 2025: TBE device provides ‘safer’ option than TEVAR for blunt thoracic injuries in setting of zone 2 coverage
Use of the Gore Tag thoracic branch endoprosthesis (TBE) “offers a safer alternative” to traditional thoracic endovascular aortic repair (TEVAR) with left subclavian artery (LSA) coverage in blunt thoracic aortic injury (BTAI) requiring zone 2 coverage for zone 2 or…
SCVS 2025: Multicenter data show favorable role for FEVAR over chimney grafts
A multi-institutional analysis has demonstrated fenestrated endovascular aneurysm repair (FEVAR) could be a “safer and more durable option” than chimney EVAR (ChEVAR) in elective juxtarenal abdominal aortic aneurysm (AAA) cases with suitable anatomy, offering potentially “greater generalizability to real-world practice.”…
SCVS issues call for abstracts as deadline approaches for 2025 symposium
The Society for Clinical Vascular Surgery (SCVS) has issued a call for abstracts for its 2025 Annual Symposium, with just under two weeks left until the deadline. Once again, the SCVS will give special consideration to papers deemed “collaboration abstracts”—those…